PTIX logo

Protagenic Therapeutics (PTIX) Cash From Financing

Annual CFF

N/A

December 31, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

PTIX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$17.46 M
PTIX annual cash flow from financing activities is currently at an all-time high

3-Year Low

$12.58 M
PTIX annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PTIX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 1, 2025
PTIX next annual earnings announcement is scheduled for Apr 1, 2025

OtherPTIXcash flowmetrics:

Annual CFI

$4.78 M
PTIX annual cash flow from investing activities is $4.78 million

Annual CFO

-$3.70 M
PTIX annual cash flow from operations is -$3.70 million

Annual FCF

-$3.85 M
PTIX annual free cash flow is -$3.85 million

Annual CAPEX

-
PTIX annual capital expenditures value is unknown

Quarterly CFF

$317.00 K
+$272.50 K+612.36%

September 30, 2024

Summary

Performance

3-Month Change

+612.36%

1-Year Change

+612.36%

3-Year Change

+612.36%

5-Year Change

+612.36%

PTIX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

56.13%
PTIX quarterly cash flow from financing activities is higher than 56.13% of companies in Healthcare sector

High & Low

All-time High

$17.64 M
PTIX quarterly cash flow from financing activities is currently -98.20% below its historical high of $17.64 million

3-Year Low

$0.00
PTIX quarterly cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PTIX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
PTIX next earnings announcement is scheduled for Apr 1, 2025

OtherPTIXcash flowmetrics:

Quarterly CFI

$0.00
PTIX quarterly cash flow from investing activities is $0.00

Quarterly CFO

-$185.70 K
PTIX quarterly cash flow from operations is -$185.70 thousand

Quarterly FCF

-$185.70 K
PTIX quarterly free cash flow is -$185.70 thousand

Quarterly CAPEX

-
PTIX quarterly capital expenditures value is unknown

TTM CFF

$361.50 K
+$317.00 K+712.36%

September 30, 2024

Summary

Performance

3-Month Change

+712.36%

1-Year Change

+712.36%

3-Year Change

+712.36%

5-Year Change

+712.36%

PTIX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.56%
PTIX TTM cash flow from financing activities is higher than 30.56% of companies in Healthcare sector

High & Low

All-time High

$18.10 M
PTIX TTM cash flow from financing activities is currently -98.00% below its historical high of $18.10 million

3-Year Low

$0.00
PTIX TTM cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PTIX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
PTIX next earnings announcement is scheduled for Apr 1, 2025

OtherPTIXcash flowmetrics:

TTM CFI

$5.08 M
PTIX TTM cash flow from investing activities is $5.08 million

TTM CFO

-$4.54 M
PTIX TTM cash flow from operations is -$4.54 million

TTM FCF

-$4.64 M
PTIX TTM free cash flow is -$4.64 million

TTM CAPEX

-
PTIX TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

PTIX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+612.4%+712.4%
3 y3 years-+612.4%+712.4%
5 y5 years-+612.4%+712.4%

PTIX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-100.0%-97.1%-100.0%
5 y5-year-97.5%-100.0%-97.2%-100.0%
alltimeall time-98.2%+115.7%-98.0%+107.3%

Protagenic Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$317.00 K(+612.4%)
$361.50 K(+712.4%)
Jun 2024
-
$44.50 K(>+9900.0%)
$44.50 K(>+9900.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2021
$12.58 M(+928.1%)
$0.00(0.0%)
$12.58 M(0.0%)
Sep 2021
-
$0.00(-100.0%)
$12.58 M(-2.5%)
Jun 2021
-
$12.45 M(+9695.8%)
$12.90 M(+1164.2%)
Mar 2021
-
$127.10 K(>+9900.0%)
$1.02 M(-16.6%)
Dec 2020
$1.22 M(+82.6%)
$0.00(-100.0%)
$1.22 M(-35.4%)
Sep 2020
-
$323.40 K(-43.3%)
$1.89 M(+20.6%)
Jun 2020
-
$570.00 K(+72.7%)
$1.57 M(+57.0%)
Mar 2020
-
$330.00 K(-50.7%)
$1.00 M(+49.3%)
Dec 2019
$670.00 K(>+9900.0%)
$670.00 K(>+9900.0%)
$670.00 K(>+9900.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2019
-
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2018
$0.00(-100.0%)
-
-
Dec 2016
$4.28 M(+1160.0%)
-$18.50 K(<-9900.0%)
$4.28 M(-2.7%)
Sep 2016
-
$0.00(-100.0%)
$4.40 M(-1.1%)
Jun 2016
-
$505.20 K(-86.7%)
$4.45 M(+10.0%)
Mar 2016
-
$3.80 M(+3697.3%)
$4.05 M(+1518.9%)
Dec 2015
-
$100.00 K(+100.0%)
$250.00 K(-16.7%)
Sep 2015
-
$50.00 K(-50.0%)
$300.00 K(-11.8%)
Jun 2015
$340.00 K(+94.3%)
$100.00 K(>+9900.0%)
$340.00 K(+41.7%)
Mar 2015
-
$0.00(-100.0%)
$240.00 K(-42.2%)
Dec 2014
-
$150.00 K(+66.7%)
$415.00 K(+56.6%)
Sep 2014
-
$90.00 K(>+9900.0%)
$265.00 K(+51.4%)
Jun 2014
$175.00 K(+464.5%)
$0.00(-100.0%)
$175.00 K(0.0%)
Mar 2014
-
$175.00 K(>+9900.0%)
$175.00 K(>+9900.0%)
Dec 2013
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(-100.0%)
$0.00(-100.0%)
Jun 2013
$31.00 K(-444.4%)
-
-
Sep 2011
-
-$2000.00(-100.0%)
$4.36 M(-0.0%)
Jun 2011
-
$4.30 M(+7587.5%)
$4.36 M(+9178.7%)
Mar 2011
-
$56.00 K(>+9900.0%)
$47.00 K(-622.2%)
Dec 2010
-$9000.00(-99.7%)
$0.00(0.0%)
-$9000.00(0.0%)
Sep 2010
-
$0.00(-100.0%)
-$9000.00(-107.0%)
Jun 2010
-
-$9000.00(<-9900.0%)
$129.00 K(-106.9%)
Mar 2010
-
$0.00(0.0%)
-$1.88 M(-33.8%)
Dec 2009
-$2.84 M
$0.00(-100.0%)
-$2.84 M(-13.8%)
Sep 2009
-
$138.00 K(-106.8%)
-$3.29 M(-33.2%)
Jun 2009
-
-$2.02 M(+110.4%)
-$4.93 M(+35.9%)
DateAnnualQuarterlyTTM
Mar 2009
-
-$959.00 K(+110.8%)
-$3.63 M(+29.4%)
Dec 2008
-$2.80 M(-116.1%)
-$455.00 K(-69.6%)
-$2.80 M(+18.8%)
Sep 2008
-
-$1.50 M(+109.2%)
-$2.36 M(+163.7%)
Jun 2008
-
-$716.00 K(+430.4%)
-$895.00 K(+190.6%)
Mar 2008
-
-$135.00 K(+1127.3%)
-$308.00 K(-101.8%)
Dec 2007
$17.46 M(-3351.8%)
-$11.00 K(-66.7%)
$17.46 M(-0.1%)
Sep 2007
-
-$33.00 K(-74.4%)
$17.47 M(-0.3%)
Jun 2007
-
-$129.00 K(-100.7%)
$17.52 M(-3.2%)
Mar 2007
-
$17.64 M(>+9900.0%)
$18.10 M(>+9900.0%)
Dec 2006
-$537.00 K(-551.3%)
-
-
Oct 2006
-
$19.00 K(-95.7%)
$87.30 K(-26.6%)
Jul 2006
-
$443.00 K(-205.9%)
$119.00 K(-136.7%)
Jul 2006
$119.00 K(+170.5%)
-
-
Apr 2006
-
-$418.20 K(-1061.4%)
-$324.00 K(-443.9%)
Jan 2006
-
$43.50 K(-14.2%)
$94.20 K(+85.8%)
Oct 2005
-
$50.70 K(-95.0%)
$50.70 K(-74.3%)
Jul 2005
$44.00 K(>+9900.0%)
-
-
Jul 2004
$0.00(-100.0%)
-
-
Apr 2003
-
$1.02 M(-196.3%)
$197.00 K(-113.1%)
Jan 2003
-
-$1.06 M(-218.3%)
-$1.51 M(+313.2%)
Oct 2002
-
$897.00 K(-235.7%)
-$365.00 K(-35.7%)
Jul 2002
-$568.00 K(-222.9%)
-$661.00 K(-3.2%)
-$568.00 K(-49.4%)
Apr 2002
-
-$683.00 K(-932.9%)
-$1.12 M(-493.7%)
Jan 2002
-
$82.00 K(-88.2%)
$285.00 K(-68.2%)
Oct 2001
-
$694.00 K(-157.1%)
$896.00 K(+93.9%)
Jul 2001
$462.00 K(-123.4%)
-$1.22 M(-267.8%)
$462.00 K(-17.8%)
Apr 2001
-
$724.00 K(+4.5%)
$562.00 K(-168.1%)
Jan 2001
-
$693.00 K(+166.5%)
-$825.00 K(-57.0%)
Oct 2000
-
$260.00 K(-123.3%)
-$1.92 M(-3.0%)
Jul 2000
-$1.98 M(-225.0%)
-$1.11 M(+68.2%)
-$1.98 M(+83.1%)
Apr 2000
-
-$663.00 K(+65.8%)
-$1.08 M(-323.6%)
Jan 2000
-
-$400.00 K(-300.0%)
$483.00 K(-50.9%)
Oct 1999
-
$200.00 K(-192.2%)
$983.00 K(-37.9%)
Jul 1999
$1.58 M(-59.1%)
-$217.00 K(-124.1%)
$1.58 M(+24.2%)
Apr 1999
-
$900.00 K(+800.0%)
$1.27 M(-7.3%)
Jan 1999
-
$100.00 K(-87.5%)
$1.38 M(-68.6%)
Oct 1998
-
$800.00 K(-252.4%)
$4.38 M(+12.9%)
Jul 1998
$3.88 M(-0.6%)
-$525.00 K(-152.5%)
$3.88 M(-11.9%)
Apr 1998
-
$1.00 M(-67.7%)
$4.40 M(+29.4%)
Jan 1998
-
$3.10 M(+933.3%)
$3.40 M(+1033.3%)
Oct 1997
-
$300.00 K
$300.00 K
Jul 1997
$3.90 M
-
-

FAQ

  • What is the all time high annual CFF for Protagenic Therapeutics?
  • What is Protagenic Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Protagenic Therapeutics?
  • What is Protagenic Therapeutics quarterly CFF year-on-year change?
  • What is Protagenic Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Protagenic Therapeutics?
  • What is Protagenic Therapeutics TTM CFF year-on-year change?

What is the all time high annual CFF for Protagenic Therapeutics?

Protagenic Therapeutics all-time high annual cash flow from financing activities is $17.46 M

What is Protagenic Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of PTIX is $317.00 K

What is the all time high quarterly CFF for Protagenic Therapeutics?

Protagenic Therapeutics all-time high quarterly cash flow from financing activities is $17.64 M

What is Protagenic Therapeutics quarterly CFF year-on-year change?

Over the past year, PTIX quarterly cash flow from financing activities has changed by +$272.50 K (+612.36%)

What is Protagenic Therapeutics TTM cash flow from financing activities?

The current TTM CFF of PTIX is $361.50 K

What is the all time high TTM CFF for Protagenic Therapeutics?

Protagenic Therapeutics all-time high TTM cash flow from financing activities is $18.10 M

What is Protagenic Therapeutics TTM CFF year-on-year change?

Over the past year, PTIX TTM cash flow from financing activities has changed by +$317.00 K (+712.36%)